Cite
HARVARD Citation
Pal, S. et al. (2020). Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell‐free DNA results. Cancer. 126 (11), pp. 2597-2606. [Online].